Nanobiotix Discloses Insider Transactions
Ticker: NBTX · Form: 6-K · Filed: May 15, 2025 · CIK: 1760854
Sentiment: neutral
Topics: insider-transaction, disclosure, 6-K
TL;DR
Nanobiotix filed a 6-K on May 15, 2025, detailing insider transactions.
AI Summary
On May 15, 2025, Nanobiotix S.A. filed a Form 6-K to disclose transactions by persons discharging managerial responsibilities. The filing serves as a notification and public disclosure of these transactions for the month of May 2025.
Why It Matters
This filing provides transparency into the trading activities of Nanobiotix's key executives and board members, which can offer insights into their confidence in the company's future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of insider transactions and does not contain new financial or operational information that would significantly alter the company's risk profile.
Key Players & Entities
- Nanobiotix S.A. (company) — Registrant
- May 15, 2025 (date) — Filing date and reporting period
FAQ
What type of transactions are being disclosed by Nanobiotix S.A. in this 6-K filing?
The filing discloses transactions by persons discharging managerial responsibilities.
What is the filing date for this Form 6-K?
The filing date is May 15, 2025.
What is the Commission File Number for Nanobiotix S.A.'s filings?
The Commission File Number is 001-39777.
Where is Nanobiotix S.A. located?
Nanobiotix S.A. is located at 60 rue de Wattignies, 75012 Paris, France.
What is the purpose of a Form 6-K filing for a foreign private issuer?
A Form 6-K is used by foreign private issuers to report information that is made public or required to be made public in their home country, or is distributed or is required to be distributed to their security holders.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 15, 2025 regarding Nanobiotix S.A. (NBTX).